内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 TES临床实践指南：类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症

2018-09-27 美国内分泌学会 J Clin Endocrinol Metab. 2018 Sep 27.

类固醇21-羟化酶缺乏先天性肾上腺增生症

2018年9月，美国内分泌学会(TES)更新发布了类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症的管理指南，是对2010年版指南的更新，专家小组基于当前证据以及专家观点针对类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症管理提出实践指导。

中文标题：

2018 TES临床实践指南：类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症

英文标题：

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

发布机构：

美国内分泌学会

发布日期：

2018-09-27

简要介绍：

2018年9月，美国内分泌学会(TES)更新发布了类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症的管理指南，是对2010年版指南的更新，专家小组基于当前证据以及专家观点针对类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症管理提出实践指导。 

拓展指南：与肾上腺皮质相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 TES临床实践指南：类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症)] GetToolGuiderByIdResponse(projectId=1, id=cf31a1c0016a88e2, title=2018 TES临床实践指南：类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症, enTitle=Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline., guiderFrom=J Clin Endocrinol Metab. 2018 Sep 27., authorId=null, author=, summary=2018年9月，美国内分泌学会(TES)更新发布了类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症的管理指南，是对2010年版指南的更新，专家小组基于当前证据以及专家观点针对类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症管理提出实践指导。 , cover=, journalId=null, articlesId=null, associationId=129, associationName=美国内分泌学会, associationIntro=美国内分泌学会（The Endocrine Society）成立于1916年，是激素研究和内分泌学临床实践世界最大、最古老，也是最活跃的机构，致力于提升公众和其他医务人员对于内分泌学的了解，提高内分泌学者在国家科研和医疗政策层面的影响。学会现拥有来自100多个国家的约14000名会员，遍布医学、分子生物学、细胞生物学、生物化学、生理学、基因学、免疫学、教育等相关领域，包括临床医生、研究员、教师、学生、内分泌学领域的相关专业人员。学会出版专业期刊和杂志，举办国际会议，为医师提供教育培训项目，发布临床实践指南，积极募集相关研究资助，推动相关政策发展。, copyright=0, guiderPublishedTime=Thu Sep 27 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年9月，美国内分泌学会(TES)更新发布了类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症的管理指南，是对2010年版指南的更新，专家小组基于当前证据以及专家观点针对类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症管理提出实践指导。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>肾上腺皮质</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=1ca891c0016215bd" title="2018 ESE临床实践指南：成人肾上腺皮质癌的管理" target=_blank>2018 ESE临床实践指南：成人肾上腺皮质癌的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a51771c00150a09a" title="2017 SCCM/ESICM指南：危重患者危重症相关性肾上腺皮质功能不全的管理" target=_blank>2017 SCCM/ESICM指南：危重患者危重症相关性肾上腺皮质功能不全的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b53671c00128031a" title="2016 先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识" target=_blank>2016 先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0161e1c001230505" title="2016 先天性肾上腺皮质增生症新生儿筛查共识" target=_blank>2016 先天性肾上腺皮质增生症新生儿筛查共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e38901c00122599b" title="2016 JES临床实践指南：肾上腺皮质功能不全（包括肾上腺危象）的诊断和治疗" target=_blank>2016 JES临床实践指南：肾上腺皮质功能不全（包括肾上腺危象）的诊断和治疗</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%BE%E4%B8%8A%E8%85%BA%E7%9A%AE%E8%B4%A8" target=_blank>有关肾上腺皮质更多指南</a></ul>, tagList=[TagDto(tagId=81521, tagName=类固醇21-羟化酶缺乏), TagDto(tagId=52598, tagName=先天性肾上腺增生症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7007, appHits=203, showAppHits=5, pcHits=5568, showPcHits=2116, likes=196, shares=8, comments=4, approvalStatus=1, publishedTime=Wed Oct 10 00:28:13 CST 2018, publishedTimeString=2018-09-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 10 00:28:13 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:39:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 TES临床实践指南：类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症)])
2018 TES临床实践指南：类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=908930, encodeId=f9299089307c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/b1abcd13be9b46ccbdae129de175993e/99752621e5834568ace14ab208cba6cc.jpg, createdBy=586c2614751, createdName=angelxuqun, createdTime=Thu Dec 17 20:11:26 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360427, encodeId=fed436042e96, content=非常感谢，分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:53 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360426, encodeId=5a313604260b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:37 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348842, encodeId=685f34884213, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Oct 11 07:36:16 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2020-12-17 angelxuqun

    想学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=908930, encodeId=f9299089307c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/b1abcd13be9b46ccbdae129de175993e/99752621e5834568ace14ab208cba6cc.jpg, createdBy=586c2614751, createdName=angelxuqun, createdTime=Thu Dec 17 20:11:26 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360427, encodeId=fed436042e96, content=非常感谢，分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:53 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360426, encodeId=5a313604260b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:37 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348842, encodeId=685f34884213, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Oct 11 07:36:16 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2019-02-11 veta

    非常感谢，分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=908930, encodeId=f9299089307c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/b1abcd13be9b46ccbdae129de175993e/99752621e5834568ace14ab208cba6cc.jpg, createdBy=586c2614751, createdName=angelxuqun, createdTime=Thu Dec 17 20:11:26 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360427, encodeId=fed436042e96, content=非常感谢，分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:53 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360426, encodeId=5a313604260b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:37 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348842, encodeId=685f34884213, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Oct 11 07:36:16 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2019-02-11 veta

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=908930, encodeId=f9299089307c, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200813/b1abcd13be9b46ccbdae129de175993e/99752621e5834568ace14ab208cba6cc.jpg, createdBy=586c2614751, createdName=angelxuqun, createdTime=Thu Dec 17 20:11:26 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360427, encodeId=fed436042e96, content=非常感谢，分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:53 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360426, encodeId=5a313604260b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/11/f055f697e39756c30ecbc4288c6868bf.jpg, createdBy=49d12083145, createdName=veta, createdTime=Mon Feb 11 22:21:37 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=348842, encodeId=685f34884213, content=谢谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Oct 11 07:36:16 CST 2018, time=2018-10-11, status=1, ipAttribution=)]
    2018-10-11 明月清辉

    谢谢分享，学习了

    0